GLOBAL OBESITY TREATMENT MARKET 2022 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2028

Jul 2022 110
Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Obesity Treatment
1.2 Classification of Obesity Treatment by Type
1.2.1 Overview: Global Obesity Treatment Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Obesity Treatment Revenue Market Share by Type in 2021
1.2.3 Surgical & Implant Devices
1.2.4 Medication Therapy
1.2.5 Dietary
1.2.6 Other
1.3 Global Obesity Treatment Market by Application
1.3.1 Overview: Global Obesity Treatment Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Children
1.3.3 Adults
1.4 Global Obesity Treatment Market Size & Forecast
1.5 Global Obesity Treatment Market Size and Forecast by Region
1.5.1 Global Obesity Treatment Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Obesity Treatment Market Size by Region, (2017-2022)
1.5.3 North America Obesity Treatment Market Size and Prospect (2017-2028)
1.5.4 Europe Obesity Treatment Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Obesity Treatment Market Size and Prospect (2017-2028)
1.5.6 South America Obesity Treatment Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Obesity Treatment Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Obesity Treatment Market Drivers
1.6.2 Obesity Treatment Market Restraints
1.6.3 Obesity Treatment Trends Analysis
2 Company Profiles
2.1 NutriSystem, Inc. (U.S.)
2.1.1 NutriSystem, Inc. (U.S.) Details
2.1.2 NutriSystem, Inc. (U.S.) Major Business
2.1.3 NutriSystem, Inc. (U.S.) Obesity Treatment Product and Solutions
2.1.4 NutriSystem, Inc. (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 NutriSystem, Inc. (U.S.) Recent Developments and Future Plans
2.2 Kellogg Company (U.S.)
2.2.1 Kellogg Company (U.S.) Details
2.2.2 Kellogg Company (U.S.) Major Business
2.2.3 Kellogg Company (U.S.) Obesity Treatment Product and Solutions
2.2.4 Kellogg Company (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Kellogg Company (U.S.) Recent Developments and Future Plans
2.3 Ethicon, Inc. (U.S.)
2.3.1 Ethicon, Inc. (U.S.) Details
2.3.2 Ethicon, Inc. (U.S.) Major Business
2.3.3 Ethicon, Inc. (U.S.) Obesity Treatment Product and Solutions
2.3.4 Ethicon, Inc. (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Ethicon, Inc. (U.S.) Recent Developments and Future Plans
2.4 Medtronic (U.S.)
2.4.1 Medtronic (U.S.) Details
2.4.2 Medtronic (U.S.) Major Business
2.4.3 Medtronic (U.S.) Obesity Treatment Product and Solutions
2.4.4 Medtronic (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Medtronic (U.S.) Recent Developments and Future Plans
2.5 F. Hoffmann-La Roche (Switzerland)
2.5.1 F. Hoffmann-La Roche (Switzerland) Details
2.5.2 F. Hoffmann-La Roche (Switzerland) Major Business
2.5.3 F. Hoffmann-La Roche (Switzerland) Obesity Treatment Product and Solutions
2.5.4 F. Hoffmann-La Roche (Switzerland) Obesity Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 F. Hoffmann-La Roche (Switzerland) Recent Developments and Future Plans
2.6 Atkins Nutritionals, Inc. (U.S.)
2.6.1 Atkins Nutritionals, Inc. (U.S.) Details
2.6.2 Atkins Nutritionals, Inc. (U.S.) Major Business
2.6.3 Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Product and Solutions
2.6.4 Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Atkins Nutritionals, Inc. (U.S.) Recent Developments and Future Plans
2.7 Herbalife Ltd. (U.S.)
2.7.1 Herbalife Ltd. (U.S.) Details
2.7.2 Herbalife Ltd. (U.S.) Major Business
2.7.3 Herbalife Ltd. (U.S.) Obesity Treatment Product and Solutions
2.7.4 Herbalife Ltd. (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Herbalife Ltd. (U.S.) Recent Developments and Future Plans
2.8 Covidien plc (U.S.)
2.8.1 Covidien plc (U.S.) Details
2.8.2 Covidien plc (U.S.) Major Business
2.8.3 Covidien plc (U.S.) Obesity Treatment Product and Solutions
2.8.4 Covidien plc (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Covidien plc (U.S.) Recent Developments and Future Plans
2.9 Apollo Endosurgery (U.S.)
2.9.1 Apollo Endosurgery (U.S.) Details
2.9.2 Apollo Endosurgery (U.S.) Major Business
2.9.3 Apollo Endosurgery (U.S.) Obesity Treatment Product and Solutions
2.9.4 Apollo Endosurgery (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Apollo Endosurgery (U.S.) Recent Developments and Future Plans
2.10 Amer Sports (Finland)
2.10.1 Amer Sports (Finland) Details
2.10.2 Amer Sports (Finland) Major Business
2.10.3 Amer Sports (Finland) Obesity Treatment Product and Solutions
2.10.4 Amer Sports (Finland) Obesity Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Amer Sports (Finland) Recent Developments and Future Plans
2.11 Johnson Health Technology, Ltd. (Taiwan)
2.11.1 Johnson Health Technology, Ltd. (Taiwan) Details
2.11.2 Johnson Health Technology, Ltd. (Taiwan) Major Business
2.11.3 Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Product and Solutions
2.11.4 Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Johnson Health Technology, Ltd. (Taiwan) Recent Developments and Future Plans
2.12 Cybex International (U.S.)
2.12.1 Cybex International (U.S.) Details
2.12.2 Cybex International (U.S.) Major Business
2.12.3 Cybex International (U.S.) Obesity Treatment Product and Solutions
2.12.4 Cybex International (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Cybex International (U.S.) Recent Developments and Future Plans
2.13 USGI Medical (U.S.)
2.13.1 USGI Medical (U.S.) Details
2.13.2 USGI Medical (U.S.) Major Business
2.13.3 USGI Medical (U.S.) Obesity Treatment Product and Solutions
2.13.4 USGI Medical (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 USGI Medical (U.S.) Recent Developments and Future Plans
2.14 Olympus Corporation (Japan)
2.14.1 Olympus Corporation (Japan) Details
2.14.2 Olympus Corporation (Japan) Major Business
2.14.3 Olympus Corporation (Japan) Obesity Treatment Product and Solutions
2.14.4 Olympus Corporation (Japan) Obesity Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Olympus Corporation (Japan) Recent Developments and Future Plans
2.15 Brunswick Corporation (U.S.)
2.15.1 Brunswick Corporation (U.S.) Details
2.15.2 Brunswick Corporation (U.S.) Major Business
2.15.3 Brunswick Corporation (U.S.) Obesity Treatment Product and Solutions
2.15.4 Brunswick Corporation (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Brunswick Corporation (U.S.) Recent Developments and Future Plans
2.16 Technogym SpA (Italy)
2.16.1 Technogym SpA (Italy) Details
2.16.2 Technogym SpA (Italy) Major Business
2.16.3 Technogym SpA (Italy) Obesity Treatment Product and Solutions
2.16.4 Technogym SpA (Italy) Obesity Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Technogym SpA (Italy) Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Obesity Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Obesity Treatment Players Market Share in 2021
3.2.2 Top 10 Obesity Treatment Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Obesity Treatment Players Head Office, Products and Services Provided
3.4 Obesity Treatment Mergers & Acquisitions
3.5 Obesity Treatment New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Obesity Treatment Revenue and Market Share by Type (2017-2022)
4.2 Global Obesity Treatment Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Obesity Treatment Revenue Market Share by Application (2017-2022)
5.2 Global Obesity Treatment Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Obesity Treatment Revenue by Type (2017-2028)
6.2 North America Obesity Treatment Revenue by Application (2017-2028)
6.3 North America Obesity Treatment Market Size by Country
6.3.1 North America Obesity Treatment Revenue by Country (2017-2028)
6.3.2 United States Obesity Treatment Market Size and Forecast (2017-2028)
6.3.3 Canada Obesity Treatment Market Size and Forecast (2017-2028)
6.3.4 Mexico Obesity Treatment Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Obesity Treatment Revenue by Type (2017-2028)
7.2 Europe Obesity Treatment Revenue by Application (2017-2028)
7.3 Europe Obesity Treatment Market Size by Country
7.3.1 Europe Obesity Treatment Revenue by Country (2017-2028)
7.3.2 Germany Obesity Treatment Market Size and Forecast (2017-2028)
7.3.3 France Obesity Treatment Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Obesity Treatment Market Size and Forecast (2017-2028)
7.3.5 Russia Obesity Treatment Market Size and Forecast (2017-2028)
7.3.6 Italy Obesity Treatment Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Obesity Treatment Revenue by Type (2017-2028)
8.2 Asia-Pacific Obesity Treatment Revenue by Application (2017-2028)
8.3 Asia-Pacific Obesity Treatment Market Size by Region
8.3.1 Asia-Pacific Obesity Treatment Revenue by Region (2017-2028)
8.3.2 China Obesity Treatment Market Size and Forecast (2017-2028)
8.3.3 Japan Obesity Treatment Market Size and Forecast (2017-2028)
8.3.4 South Korea Obesity Treatment Market Size and Forecast (2017-2028)
8.3.5 India Obesity Treatment Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Obesity Treatment Market Size and Forecast (2017-2028)
8.3.7 Australia Obesity Treatment Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Obesity Treatment Revenue by Type (2017-2028)
9.2 South America Obesity Treatment Revenue by Application (2017-2028)
9.3 South America Obesity Treatment Market Size by Country
9.3.1 South America Obesity Treatment Revenue by Country (2017-2028)
9.3.2 Brazil Obesity Treatment Market Size and Forecast (2017-2028)
9.3.3 Argentina Obesity Treatment Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Obesity Treatment Revenue by Type (2017-2028)
10.2 Middle East & Africa Obesity Treatment Revenue by Application (2017-2028)
10.3 Middle East & Africa Obesity Treatment Market Size by Country
10.3.1 Middle East & Africa Obesity Treatment Revenue by Country (2017-2028)
10.3.2 Turkey Obesity Treatment Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Obesity Treatment Market Size and Forecast (2017-2028)
10.3.4 UAE Obesity Treatment Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Obesity Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Obesity Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Obesity Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Obesity Treatment Revenue (USD Million) by Region (2017-2022)
Table 5. Global Obesity Treatment Revenue Market Share by Region (2023-2028)
Table 6. NutriSystem, Inc. (U.S.) Corporate Information, Head Office, and Major Competitors
Table 7. NutriSystem, Inc. (U.S.) Major Business
Table 8. NutriSystem, Inc. (U.S.) Obesity Treatment Product and Solutions
Table 9. NutriSystem, Inc. (U.S.) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Kellogg Company (U.S.) Corporate Information, Head Office, and Major Competitors
Table 11. Kellogg Company (U.S.) Major Business
Table 12. Kellogg Company (U.S.) Obesity Treatment Product and Solutions
Table 13. Kellogg Company (U.S.) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Ethicon, Inc. (U.S.) Corporate Information, Head Office, and Major Competitors
Table 15. Ethicon, Inc. (U.S.) Major Business
Table 16. Ethicon, Inc. (U.S.) Obesity Treatment Product and Solutions
Table 17. Ethicon, Inc. (U.S.) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Medtronic (U.S.) Corporate Information, Head Office, and Major Competitors
Table 19. Medtronic (U.S.) Major Business
Table 20. Medtronic (U.S.) Obesity Treatment Product and Solutions
Table 21. Medtronic (U.S.) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. F. Hoffmann-La Roche (Switzerland) Corporate Information, Head Office, and Major Competitors
Table 23. F. Hoffmann-La Roche (Switzerland) Major Business
Table 24. F. Hoffmann-La Roche (Switzerland) Obesity Treatment Product and Solutions
Table 25. F. Hoffmann-La Roche (Switzerland) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Atkins Nutritionals, Inc. (U.S.) Corporate Information, Head Office, and Major Competitors
Table 27. Atkins Nutritionals, Inc. (U.S.) Major Business
Table 28. Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Product and Solutions
Table 29. Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Herbalife Ltd. (U.S.) Corporate Information, Head Office, and Major Competitors
Table 31. Herbalife Ltd. (U.S.) Major Business
Table 32. Herbalife Ltd. (U.S.) Obesity Treatment Product and Solutions
Table 33. Herbalife Ltd. (U.S.) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Covidien plc (U.S.) Corporate Information, Head Office, and Major Competitors
Table 35. Covidien plc (U.S.) Major Business
Table 36. Covidien plc (U.S.) Obesity Treatment Product and Solutions
Table 37. Covidien plc (U.S.) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Apollo Endosurgery (U.S.) Corporate Information, Head Office, and Major Competitors
Table 39. Apollo Endosurgery (U.S.) Major Business
Table 40. Apollo Endosurgery (U.S.) Obesity Treatment Product and Solutions
Table 41. Apollo Endosurgery (U.S.) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Amer Sports (Finland) Corporate Information, Head Office, and Major Competitors
Table 43. Amer Sports (Finland) Major Business
Table 44. Amer Sports (Finland) Obesity Treatment Product and Solutions
Table 45. Amer Sports (Finland) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Johnson Health Technology, Ltd. (Taiwan) Corporate Information, Head Office, and Major Competitors
Table 47. Johnson Health Technology, Ltd. (Taiwan) Major Business
Table 48. Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Product and Solutions
Table 49. Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Cybex International (U.S.) Corporate Information, Head Office, and Major Competitors
Table 51. Cybex International (U.S.) Major Business
Table 52. Cybex International (U.S.) Obesity Treatment Product and Solutions
Table 53. Cybex International (U.S.) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. USGI Medical (U.S.) Corporate Information, Head Office, and Major Competitors
Table 55. USGI Medical (U.S.) Major Business
Table 56. USGI Medical (U.S.) Obesity Treatment Product and Solutions
Table 57. USGI Medical (U.S.) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Olympus Corporation (Japan) Corporate Information, Head Office, and Major Competitors
Table 59. Olympus Corporation (Japan) Major Business
Table 60. Olympus Corporation (Japan) Obesity Treatment Product and Solutions
Table 61. Olympus Corporation (Japan) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Brunswick Corporation (U.S.) Corporate Information, Head Office, and Major Competitors
Table 63. Brunswick Corporation (U.S.) Major Business
Table 64. Brunswick Corporation (U.S.) Obesity Treatment Product and Solutions
Table 65. Brunswick Corporation (U.S.) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Technogym SpA (Italy) Corporate Information, Head Office, and Major Competitors
Table 67. Technogym SpA (Italy) Major Business
Table 68. Technogym SpA (Italy) Obesity Treatment Product and Solutions
Table 69. Technogym SpA (Italy) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Global Obesity Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 71. Global Obesity Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 72. Breakdown of Obesity Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Obesity Treatment Players Head Office, Products and Services Provided
Table 74. Obesity Treatment Mergers & Acquisitions in the Past Five Years
Table 75. Obesity Treatment New Entrants and Expansion Plans
Table 76. Global Obesity Treatment Revenue (USD Million) by Type (2017-2022)
Table 77. Global Obesity Treatment Revenue Share by Type (2017-2022)
Table 78. Global Obesity Treatment Revenue Forecast by Type (2023-2028)
Table 79. Global Obesity Treatment Revenue by Application (2017-2022)
Table 80. Global Obesity Treatment Revenue Forecast by Application (2023-2028)
Table 81. North America Obesity Treatment Revenue by Type (2017-2022) & (USD Million)
Table 82. North America Obesity Treatment Revenue by Type (2023-2028) & (USD Million)
Table 83. North America Obesity Treatment Revenue by Application (2017-2022) & (USD Million)
Table 84. North America Obesity Treatment Revenue by Application (2023-2028) & (USD Million)
Table 85. North America Obesity Treatment Revenue by Country (2017-2022) & (USD Million)
Table 86. North America Obesity Treatment Revenue by Country (2023-2028) & (USD Million)
Table 87. Europe Obesity Treatment Revenue by Type (2017-2022) & (USD Million)
Table 88. Europe Obesity Treatment Revenue by Type (2023-2028) & (USD Million)
Table 89. Europe Obesity Treatment Revenue by Application (2017-2022) & (USD Million)
Table 90. Europe Obesity Treatment Revenue by Application (2023-2028) & (USD Million)
Table 91. Europe Obesity Treatment Revenue by Country (2017-2022) & (USD Million)
Table 92. Europe Obesity Treatment Revenue by Country (2023-2028) & (USD Million)
Table 93. Asia-Pacific Obesity Treatment Revenue by Type (2017-2022) & (USD Million)
Table 94. Asia-Pacific Obesity Treatment Revenue by Type (2023-2028) & (USD Million)
Table 95. Asia-Pacific Obesity Treatment Revenue by Application (2017-2022) & (USD Million)
Table 96. Asia-Pacific Obesity Treatment Revenue by Application (2023-2028) & (USD Million)
Table 97. Asia-Pacific Obesity Treatment Revenue by Region (2017-2022) & (USD Million)
Table 98. Asia-Pacific Obesity Treatment Revenue by Region (2023-2028) & (USD Million)
Table 99. South America Obesity Treatment Revenue by Type (2017-2022) & (USD Million)
Table 100. South America Obesity Treatment Revenue by Type (2023-2028) & (USD Million)
Table 101. South America Obesity Treatment Revenue by Application (2017-2022) & (USD Million)
Table 102. South America Obesity Treatment Revenue by Application (2023-2028) & (USD Million)
Table 103. South America Obesity Treatment Revenue by Country (2017-2022) & (USD Million)
Table 104. South America Obesity Treatment Revenue by Country (2023-2028) & (USD Million)
Table 105. Middle East & Africa Obesity Treatment Revenue by Type (2017-2022) & (USD Million)
Table 106. Middle East & Africa Obesity Treatment Revenue by Type (2023-2028) & (USD Million)
Table 107. Middle East & Africa Obesity Treatment Revenue by Application (2017-2022) & (USD Million)
Table 108. Middle East & Africa Obesity Treatment Revenue by Application (2023-2028) & (USD Million)
Table 109. Middle East & Africa Obesity Treatment Revenue by Country (2017-2022) & (USD Million)
Table 110. Middle East & Africa Obesity Treatment Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Obesity Treatment Picture
Figure 2. Global Obesity Treatment Revenue Market Share by Type in 2021
Figure 3. Surgical & Implant Devices
Figure 4. Medication Therapy
Figure 5. Dietary
Figure 6. Other
Figure 7. Obesity Treatment Revenue Market Share by Application in 2021
Figure 8. Children Picture
Figure 9. Adults Picture
Figure 10. Global Obesity Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global Obesity Treatment Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Obesity Treatment Revenue Market Share by Region (2017-2028)
Figure 13. Global Obesity Treatment Revenue Market Share by Region in 2021
Figure 14. North America Obesity Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe Obesity Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific Obesity Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America Obesity Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa Obesity Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Obesity Treatment Market Drivers
Figure 20. Obesity Treatment Market Restraints
Figure 21. Obesity Treatment Market Trends
Figure 22. NutriSystem, Inc. (U.S.) Recent Developments and Future Plans
Figure 23. Kellogg Company (U.S.) Recent Developments and Future Plans
Figure 24. Ethicon, Inc. (U.S.) Recent Developments and Future Plans
Figure 25. Medtronic (U.S.) Recent Developments and Future Plans
Figure 26. F. Hoffmann-La Roche (Switzerland) Recent Developments and Future Plans
Figure 27. Atkins Nutritionals, Inc. (U.S.) Recent Developments and Future Plans
Figure 28. Herbalife Ltd. (U.S.) Recent Developments and Future Plans
Figure 29. Covidien plc (U.S.) Recent Developments and Future Plans
Figure 30. Apollo Endosurgery (U.S.) Recent Developments and Future Plans
Figure 31. Amer Sports (Finland) Recent Developments and Future Plans
Figure 32. Johnson Health Technology, Ltd. (Taiwan) Recent Developments and Future Plans
Figure 33. Cybex International (U.S.) Recent Developments and Future Plans
Figure 34. USGI Medical (U.S.) Recent Developments and Future Plans
Figure 35. Olympus Corporation (Japan) Recent Developments and Future Plans
Figure 36. Brunswick Corporation (U.S.) Recent Developments and Future Plans
Figure 37. Technogym SpA (Italy) Recent Developments and Future Plans
Figure 38. Global Obesity Treatment Revenue Share by Players in 2021
Figure 39. Obesity Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 40. Global Top 3 Players Obesity Treatment Revenue Market Share in 2021
Figure 41. Global Top 10 Players Obesity Treatment Revenue Market Share in 2021
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 43. Global Obesity Treatment Revenue Share by Type in 2021
Figure 44. Global Obesity Treatment Market Share Forecast by Type (2023-2028)
Figure 45. Global Obesity Treatment Revenue Share by Application in 2021
Figure 46. Global Obesity Treatment Market Share Forecast by Application (2023-2028)
Figure 47. North America Obesity Treatment Sales Market Share by Type (2017-2028)
Figure 48. North America Obesity Treatment Sales Market Share by Application (2017-2028)
Figure 49. North America Obesity Treatment Revenue Market Share by Country (2017-2028)
Figure 50. United States Obesity Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Canada Obesity Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Mexico Obesity Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Europe Obesity Treatment Sales Market Share by Type (2017-2028)
Figure 54. Europe Obesity Treatment Sales Market Share by Application (2017-2028)
Figure 55. Europe Obesity Treatment Revenue Market Share by Country (2017-2028)
Figure 56. Germany Obesity Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. France Obesity Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. United Kingdom Obesity Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Russia Obesity Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Italy Obesity Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Asia-Pacific Obesity Treatment Sales Market Share by Type (2017-2028)
Figure 62. Asia-Pacific Obesity Treatment Sales Market Share by Application (2017-2028)
Figure 63. Asia-Pacific Obesity Treatment Revenue Market Share by Region (2017-2028)
Figure 64. China Obesity Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Japan Obesity Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South Korea Obesity Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. India Obesity Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Southeast Asia Obesity Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Australia Obesity Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South America Obesity Treatment Sales Market Share by Type (2017-2028)
Figure 71. South America Obesity Treatment Sales Market Share by Application (2017-2028)
Figure 72. South America Obesity Treatment Revenue Market Share by Country (2017-2028)
Figure 73. Brazil Obesity Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina Obesity Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East and Africa Obesity Treatment Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Obesity Treatment Sales Market Share by Application (2017-2028)
Figure 77. Middle East and Africa Obesity Treatment Revenue Market Share by Country (2017-2028)
Figure 78. Turkey Obesity Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Obesity Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. UAE Obesity Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source

Table of Contents

Related reports :

(Sep 22)

This report studies the global Elderly Wheelchair production, demand, key manufacturers, and key regions. This report is a detailed a...

(Sep 22)

According to our (Global Info Research) latest study, the global Elderly Wheelchair market size was valued at USD million in 2021 and is for...

(Sep 22)

Suture anchors are broadly used for attaching soft tissue (e.g., tendons, ligaments, and meniscus) to the bone and have become essential dev...

(Sep 22)

Suture anchors are broadly used for attaching soft tissue (e.g., tendons, ligaments, and meniscus) to the bone and have become essential dev...

(Sep 22)

Barbed sutures are primarily used in cosmetic surgery. In recent years there has been an increasing uptake in the use of barbed sutures, par...

(Sep 22)

Barbed sutures are primarily used in cosmetic surgery. In recent years there has been an increasing uptake in the use of barbed sutures, par...

Global Info Research

GLOBAL OBESITY TREATMENT MARKET 2022 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2028

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medical Devices market as per your needs. Get the best of Medical Devices research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy